Unknown

Dataset Information

Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties.


ABSTRACT:

Background

The transcription factor NF-κB drives neoplastic progression of many cancers including primary brain tumors (glioblastoma [GBM]). Precise therapeutic modulation of NF-κB activity can suppress central oncogenic signaling pathways in GBM, but clinically applicable compounds to achieve this goal have remained elusive.

Methods

In a pharmacogenomics study with a panel of transgenic glioma cells, we observed that NF-κB can be converted into a tumor suppressor by the non-psychotropic cannabinoid cannabidiol (CBD). Subsequently, we investigated the anti-tumor effects of CBD, which is used as an anticonvulsive drug (Epidiolex) in pediatric neurology, in a larger set of human primary GBM stem-like cells (hGSC). For this study, we performed pharmacological assays, gene expre

SUBMITTER: Volmar MNM 

PROVIDER: S-EPMC8563328 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature